Goldman Sachs’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-722,369
| Closed | -$82K | – | 4318 |
|
|
2018
Q4 | $82K | Buy |
722,369
+30,890
| +4% | +$3.51K | ﹤0.01% | 3919 |
|
|
2018
Q3 | $1.18M | Sell |
691,479
-82,516
| -11% | -$140K | ﹤0.01% | 3114 |
|
|
2018
Q2 | $1.35M | Sell |
773,995
-786,152
| -50% | -$1.37M | ﹤0.01% | 3058 |
|
|
2018
Q1 | $2.86M | Sell |
1,560,147
-465,932
| -23% | -$853K | ﹤0.01% | 2661 |
|
|
2017
Q4 | $4.52M | Sell |
2,026,079
-1,291,591
| -39% | -$2.88M | ﹤0.01% | 2354 |
|
|
2017
Q3 | $9.62M | Buy |
3,317,670
+1,109,945
| +50% | +$3.22M | ﹤0.01% | 1992 |
|
|
2017
Q2 | $9.82M | Buy |
2,207,725
+782,648
| +55% | +$3.48M | ﹤0.01% | 1936 |
|
|
2017
Q1 | $6.64M | Buy |
1,425,077
+411,699
| +41% | +$1.92M | ﹤0.01% | 2044 |
|
|
2016
Q4 | $6.17M | Buy |
1,013,378
+360,831
| +55% | +$2.2M | ﹤0.01% | 2066 |
|
|
2016
Q3 | $3.6M | Buy |
652,547
+121,412
| +23% | +$669K | ﹤0.01% | 2415 |
|
|
2016
Q2 | $2.02M | Sell |
531,135
-25,493
| -5% | -$96.9K | ﹤0.01% | 2608 |
|
|
2016
Q1 | $1.54M | Buy |
556,628
+220,145
| +65% | +$607K | ﹤0.01% | 2662 |
|
|
2015
Q4 | $1.91M | Buy |
336,483
+174,745
| +108% | +$991K | ﹤0.01% | 2547 |
|
|
2015
Q3 | $857K | Buy |
161,738
+21,024
| +15% | +$111K | ﹤0.01% | 2997 |
|
|
2015
Q2 | $1.17M | Buy |
140,714
+10,872
| +8% | +$90.2K | ﹤0.01% | 2877 |
|
|
2015
Q1 | $600K | Sell |
129,842
-16,364
| -11% | -$75.6K | ﹤0.01% | 3200 |
|
|
2014
Q4 | $446K | Sell |
146,206
-18,599
| -11% | -$56.7K | ﹤0.01% | 3442 |
|
|
2014
Q3 | $459K | Buy |
164,805
+111,328
| +208% | +$310K | ﹤0.01% | 3383 |
|
|
2014
Q2 | $218K | Sell |
53,477
-10,558
| -16% | -$43K | ﹤0.01% | 3924 |
|
|
2014
Q1 | $340K | Buy |
64,035
+8,874
| +16% | +$47.1K | ﹤0.01% | 3606 |
|
|
2013
Q4 | $306K | Buy |
55,161
+36,801
| +200% | +$204K | ﹤0.01% | 3687 |
|
|
2013
Q3 | $83K | Buy |
18,360
+3,521
| +24% | +$15.9K | ﹤0.01% | 4045 |
|
|
2013
Q2 | $63K | Buy |
+14,839
| New | +$63K | ﹤0.01% | 3860 |
|